Which antihistamine and dosage is appropriate for a 14‑month‑old infant?

Antihistamine for a 14-Month-Old Infant

Direct Recommendation

For a 14-month-old infant requiring antihistamine therapy, cetirizine 2.5 mg once or twice daily is the recommended first-line agent, as it is one of only two antihistamines with FDA approval and documented safety data for children under 2 years of age. 1, 2

---

Approved Medications and Dosing

First-Line: Cetirizine

• Cetirizine is dosed at 2.5 mg once or twice daily (equivalent to 0.25 mg/kg BID for a typical 10 kg infant) for children aged 6 months to 2 years. 1, 2
• Liquid formulations are strongly preferred because they provide easier administration and better absorption in infants. 1, 2
• Cetirizine and loratadine are the only two antihistamines with FDA approval for use in children younger than 2 years. 2

Alternative: Loratadine

• Loratadine may be considered as an alternative, though it is FDA-approved for children 2-5 years at 5 mg once daily; dosing for a 14-month-old must be determined by a physician. 1, 2
• For children under 2 years, cetirizine has more robust safety data than loratadine. 1

---

Critical Safety Warnings

Medications to Avoid

• First-generation antihistamines (diphenhydramine, hydroxyzine, chlorphenamine) should NEVER be used for routine allergic symptoms in children under 6 years due to significant mortality risk. 1, 2, 3
• Between 1969 and 2006,69 deaths in children under 6 years were linked to antihistamines, with 41 deaths occurring in children under 2 years; diphenhydramine alone was responsible for 33 of these fatalities. 1, 2, 3
• The FDA and American Academy of Pediatrics explicitly recommend against over-the-counter cough-and-cold products containing first-generation antihistamines in children under 6 years. 1, 2, 3

Contraindicated Uses

• Using antihistamines "to make a child sleepy" is explicitly contraindicated per FDA labeling. 1, 2
• OTC cough-and-cold combination products must be avoided in children under 6 years due to overdose risk from multiple active ingredients. 1, 2

---

Clinical Algorithm for Allergic Symptoms

Mild Symptoms (few hives, mild itching, watery eyes)

• Administer cetirizine 2.5 mg orally once daily as first-line therapy. 1
• Monitor for sedation, though it is uncommon at recommended doses. 2

Moderate-to-Severe Symptoms (diffuse hives, respiratory symptoms, lip/tongue swelling)

• Administer epinephrine 0.15 mg intramuscularly immediately (for infants 10-25 kg). 1
• Call emergency services and transport to emergency department. 1
• Diphenhydramine may be added as adjunctive therapy ONLY under direct medical supervision at 1-2 mg/kg (maximum 50 mg), but epinephrine remains the only first-line treatment. 1

Anaphylaxis

• Epinephrine is the only first-line treatment; repeat every 5-15 minutes if symptoms persist. 1
• Antihistamines are purely adjunctive and should never replace epinephrine. 1, 3

---

Special Considerations

When Intranasal Corticosteroids Are Superior

• For allergic rhinitis specifically, intranasal corticosteroids are the most effective medication class for controlling all symptoms and should be considered first-line therapy. 2, 3
• Cetirizine may be added as second-line or adjunctive therapy if intranasal corticosteroids alone are insufficient. 2
• At recommended doses, intranasal corticosteroids are not associated with clinically significant systemic side effects. 2

Atopic Dermatitis

• Antihistamines should NOT be routinely used for atopic dermatitis management, as 16 randomized controlled trials demonstrate that non-sedating antihistamines are ineffectual for this condition. 4, 3
• Short-term, intermittent use of sedating antihistamines may benefit sleep loss secondary to itch, but should not substitute for topical therapies. 4

Renal Impairment

• Cetirizine requires 50% dose reduction in moderate renal impairment and should be avoided in severe renal impairment. 3

---

Common Pitfalls to Avoid

• Do not prescribe diphenhydramine for routine allergy relief in a 14-month-old; the mortality risk outweighs any potential benefit. 1, 2, 3
• Do not use antihistamines as monotherapy for anaphylaxis; epinephrine must always be given first. 1, 3
• Do not select combination cough-and-cold products, as they increase overdose risk from multiple active ingredients. 1, 2
• Do not assume all second-generation antihistamines are FDA-approved for infants; only cetirizine and loratadine have approval for children under 2 years. 2
• Do not use antihistamines to prevent wheezing or asthma in infants with atopic dermatitis or family history of allergy, as the risk of side effects outweighs uncertain preventive benefits. 1

---

Monitoring and Follow-Up

• No laboratory monitoring is required for cetirizine at therapeutic doses. 4
• Monitor for sedation, particularly if higher-than-usual doses are used. 2
• If recurrent allergic symptoms require ongoing antihistamine use, refer to a pediatric allergist for diagnostic testing, trigger identification, and comprehensive management planning. 1